Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: a randomised controlled trial.
- DOI
- 10.1016/j.jinf.2026.106784
- Published
- 2026 Aug
- Container
- The Journal of infection
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jinf.2026.106784,
title = {Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: a randomised controlled trial.},
author = {Harris R and Thirard R and McBrien C and Middleditch A and Chadwick D and Jackson J and Moran E and Perry J and Payne RA and Goodman AL and Cosgrove C and Lillie P and Emmett S and Finn A and Pike K and Culliford L and Lazarus R and ZosterFluCov Trial team},
year = {2026},
journal = {The Journal of infection},
doi = {10.1016/j.jinf.2026.106784},
url = {https://doi.org/10.1016/j.jinf.2026.106784}
}RIS
TY - JOUR TI - Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: a randomised controlled trial. AU - Harris R AU - Thirard R AU - McBrien C AU - Middleditch A AU - Chadwick D AU - Jackson J AU - Moran E AU - Perry J AU - Payne RA AU - Goodman AL AU - Cosgrove C AU - Lillie P AU - Emmett S AU - Finn A AU - Pike K AU - Culliford L AU - Lazarus R AU - ZosterFluCov Trial team PY - 2026 JO - The Journal of infection DO - 10.1016/j.jinf.2026.106784 UR - https://doi.org/10.1016/j.jinf.2026.106784 ER -
APA
R, H., R, T., C, M., A, M., D, C., J, J., E, M., J, P., RA, P., AL, G., C, C., P, L., S, E., A, F., K, P., L, C., R, L., & team, Z. T. (2026). Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: a randomised controlled trial.. The Journal of infection. https://doi.org/10.1016/j.jinf.2026.106784
Source records
- pubmed · retrieved 2026-09-26T08:53:30.274Z